SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis

SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis

IntroductionPheochromocytomas and paragangliomas (PCC/PGL) are rare neuroendocrine tumors and can secrete catecholamine. Previous studies have found that SDHB immunohistochemistry (IHC) can predict SDHB germline gene mutation, and SDHB mutation is closely associated with tumor progression and metast...

Full description

Bibliographic Details
Main Authors:	Tingwei Su, Yifan Yang, Lei Jiang, Jing Xie, Xu Zhong, Luming Wu, Yiran Jiang, Cui Zhang, Weiwei Zhou, Lei Ye, Guang Ning, Weiqing Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Endocrinology
Subjects:	SDHB immunohistochemistry pheochromocytomas and paragangliomas tumor progression prognosis retrospective prospective
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1121397/full

Similar Items

Efficacy of Immunohistochemistry for SDHB in the Screening of Hereditary Pheochromocytoma–Paraganglioma
by: Hye-Ryeon Choi, et al.
Published: (2021-07-01)

Novel and recurrent genetic variants of VHL, SDHB, and RET genes in Chinese pheochromocytoma and paraganglioma patients
by: Chong Li, et al.
Published: (2023-03-01)

Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
by: Balazs Sarkadi, et al.
Published: (2020-03-01)

Targeting NRF2-Governed Glutathione Synthesis for <i>SDHB</i>-Mutated Pheochromocytoma and Paraganglioma
by: Yang Liu, et al.
Published: (2020-01-01)

Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa
by: Debra M Gordon, et al.
Published: (2022-02-01)

Development and internal validation of a novel predictive model for SDHB mutations in pheochromocytomas and retroperitoneal paragangliomas
by: Yue Zhou, et al.
Published: (2023-12-01)

Increased Mortality in SDHB but Not in SDHD Pathogenic Variant Carriers
by: Johannes A. Rijken, et al.
Published: (2019-01-01)

Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma
by: Trisha Dwight, et al.
Published: (2017-07-01)

Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients
by: Yuto Yamazaki, et al.
Published: (2020-10-01)

Research progress on the pathogenesis of the SDHB mutation and related diseases
by: Chang Liu, et al.
Published: (2023-11-01)

Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature
by: Anli Tong, et al.
Published: (2020-02-01)

Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of Origin
by: Karen Koopman, et al.
Published: (2019-07-01)

Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma
by: Masato Yonamine, et al.
Published: (2021-08-01)

SDHB and SDHA Immunohistochemistry in Canine Pheochromocytomas
by: Firas M. Abed, et al.
Published: (2020-09-01)

Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
by: Yiqiang Huang, et al.
Published: (2018-11-01)

Molecular Alterations in Dog Pheochromocytomas and Paragangliomas
by: Esther Korpershoek, et al.
Published: (2019-04-01)

Missed clinical clues in patients with pheochromocytoma/paraganglioma discovered by imaging
by: Natalie Rogowski-Lehmann, et al.
Published: (2018-10-01)

Exome sequencing and SDH (A, B) immunohistochemistry of canine Pheochromocytomas
by: Firas M. Abed, et al.
Published: (2022-12-01)

Tumor characteristics and surgical outcome in incidentally discovered pheochromocytomas and paragangliomas
by: Xinlei Chen, et al.
Published: (2018-10-01)

The Clinical Characteristics of Pheochromocytomas and Paragangliomas with Negative Catecholamines
by: Lin Zhao, et al.
Published: (2022-09-01)

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
by: Eu Jeong Ku, et al.
Published: (2021-04-01)

Paraganglioma intraabdominal por mutación de SDHB. A propósito de un caso
by: Javier Bodoque Cubas, et al.
Published: (2022-01-01)

The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management
by: José Viana Lima Junior, et al.
Published: (2023-06-01)

Renal hilar pheochromocytoma with nonfunctional kidney
by: Amit Tuli, et al.
Published: (2018-01-01)

Roxadustat reduced the risk of perioperative complication arising from the treatment of cardiac paraganglioma: A case report
by: Dong Wang, et al.
Published: (2023-09-01)

Update on Modern Management of Pheochromocytoma and Paraganglioma
by: Jacques W. M. Lenders, et al.
Published: (2017-06-01)

Bladder Paraganglioma Presenting as Post-Micturition Syncope
by: Maria Tomkins, et al.
Published: (2022-09-01)

SDHB exon 1 deletion: A recurrent germline mutation in Colombian patients with pheochromocytomas and paragangliomas
by: María Carolina Manotas, et al.
Published: (2023-01-01)

Rare vertebral metastasis in a case of Hereditary Paraganglioma
by: da Silva Manuel Eduardo, et al.
Published: (2012-09-01)

Characteristics of pediatric pheochromocytoma/paraganglioma
by: Vijaya Sarathi
Published: (2017-01-01)

Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas
by: Anastasiya Snezhkina, et al.
Published: (2021-11-01)

Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma
by: Radovan Bílek, et al.
Published: (2019-04-01)

Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
by: Alberto Cascón, et al.
Published: (2019-05-01)

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
by: Song Peng, et al.
Published: (2020-11-01)

An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma
by: Ali S. Alzahrani, et al.
Published: (2023-12-01)

Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas
by: Lin Zhao, et al.
Published: (2023-12-01)

Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review
by: Xu Wang, et al.
Published: (2023-04-01)

The use of temozolomide in paediatric metastatic phaeochromocytoma/paraganglioma: A case report and literature review
by: Calum Urquhart, et al.
Published: (2022-11-01)

Long-Term Outcomes after Surgery for Pheochromocytoma and Sympathetic Paraganglioma
by: Francesca Torresan, et al.
Published: (2023-05-01)

New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications
by: Sakshi Jhawar, et al.
Published: (2022-01-01)